The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 409-415

  Belyansky, Igor ^a   Tsirline, Victor B ^a   Martin, Terri R ^a   Klima, David A ^a   Heath, Jessica ^a   Lincourt, Amy E ^a   Satishkumar, Rohan ^a   Vertegel, Alexey ^a   Heniford, B Todd ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

antimicrobials; biologics; hernia; infection; lysostaphin; porcine mesh

Indexed keywords

LYSOSTAPHIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; MALE; NONHUMAN; PORCINE MESH; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS INFECTION; RAT; SHEAR STRENGTH; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SURVIVAL; TENSILE STRENGTH;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BIOCOMPATIBLE MATERIALS; FASCIA; HERNIA, ABDOMINAL; LYSOSTAPHIN; MALE; RATS; RATS, INBRED LEW; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL MESH; SURGICAL WOUND INFECTION; SWINE; TENSILE STRENGTH;

EID: 81155131260     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.04.014     Document Type: Article

References (32)

1. E.B. Wassenaar, E.J. Schoenmaeckers, and J.T. Raymakers Recurrences after laparoscopic repair of ventral and incisional hernia: Lessons learned from 505 repairs Surg Endosc 23 2009 825
2. W.W. Vrijland, M.P. van den Tol, and R.W. Luijendijk Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia Br J Surg 89 2002 293
3. G.E. Leber, J.L. Garb, and A.I. Alexander Long-term complications associated with prosthetic repair of incisional hernias Arch Surg 133 1998 378
4. I.M. Rutkow Demographic and socioeconomic aspects of hernia repair in the United States in 2003 Surg Clin North Am 83 2003 1045 v-vi
5. K. Junge, R. Rosch, and C.J. Krones Influence of polyglecaprone 25 (Monocryl) supplementation on the biocompatibility of a polypropylene mesh for hernia repair Hernia 9 2005 212
6. D.J. Anderson, D.J. Sexton, and Z.A. Kanafani Severe surgical site infection in community hospitals: Epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus Infect Control Hosp Epidemiol 28 2007 1047
7. M.E. Falagas, and S.K. Kasiakou Mesh-related infections after hernia repair surgery Clin Microbiol Infect 11 2005 3
8. I.A. Bliziotis, S.K. Kasiakou, and A.M. Kapaskelis Mesh-related infection after hernia repair: Case report of an emerging type of foreign-body related infection Infection 34 2006 46
9. M. Otto Staphylococcal biofilms Curr Top Microbiol Immunol 322 2008 207
10. J.W. Costerton, P.S. Stewart, and E.P. Greenberg Bacterial biofilms: A common cause of persistent infections Science 284 1999 1318
11. K.W. Kercher, R.F. Sing, and B.D. Matthews Successful salvage of infected PTFE mesh after ventral hernia repair Ostomy Wound Manage 48 2002 40
12. B.L. Paton, Y.W. Novitsky, and M. Zerey Management of infections of polytetrafluoroethylene-based mesh Surg Infect (Larchmt) 8 2007 337
13. S. Petersen, G. Henke, and M. Freitag Deep prosthesis infection in incisional hernia repair: Predictive factors and clinical outcome Eur J Surg 167 2001 453
14. B. Aguilar, A.B. Chapital, and J.A. Madura 2nd Conservative management of mesh-site infection in hernia repair J Laparoendosc Adv Surg Tech A 20 2010 249
15. W.S. Cobb, B.L. Paton, and Y.W. Novitsky Intra-abdominal placement of antimicrobial-impregnated mesh is associated with noninfectious fever Am Surg 72 2006 1205 discussion 1208
16. C. Pastor, A. Artinyan, and M.G. Varma An increase in compliance with the Surgical Care Improvement Project measures does not prevent surgical site infection in colorectal surgery Dis Colon Rectum 53 2010 24
17. J.E. Keller, C.J. Dolce, and K.C. Walters Effect of bacterial exposure on acellular human dermis in a rat ventral hernia model J Surg Res 162 2010 148
18. M.L. Milburn, L.H. Holton, and T.L. Chung Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of perioperative Staphylococcus aureus implant contamination: A rabbit model Surg Infect (Larchmt) 9 2008 433
19. B.F. King, M.L. Biel, and B.J. Wilkinson Facile penetration of the Staphylococcus aureus capsule by lysostaphin Infect Immun 29 1980 892
20. G. Francius, O. Domenech, and M.P. Mingeot-Leclercq Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin J Bacteriol 190 2008 7904
21. J.K. Kumar Lysostaphin: An antistaphylococcal agent Appl Microbiol Biotechnol 80 2008 555
22. J.F. Kokai-Kun, T. Chanturiya, and J.J. Mond Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice J Antimicrob Chemother 64 2009 94
23. R. Satishkumar, S. Sankar, and Y. Yurko Evaluation of antimicrobial activity of lysostaphin-coated hernia repair meshes Antimicrob Agents Chemother 2011 in press
24. W. Schaffner, M.A. Melly, and M.G. Koenig Lysostaphin: An enzymatic approach to staphylococcal disease. II. In vivo studies Yale J Biol Med 39 1967 230
25. M. Deysine Pathophysiology, prevention, and management of prosthetic infections in hernia surgery Surg Clin North Am 78 1998 1105-15, viii
26. J.M. Bellon, J. Bujan, and L. Contreras Integration of biomaterials implanted into abdominal wall: Process of scar formation and macrophage response Biomaterials 16 1995 381
27. M. Hiles, R.D. Record Ritchie, and A.M. Altizer Are biologic grafts effective for hernia repair?: A systematic review of the literature Surg Innov 16 2009 26
28. K.C. Harth, and M.J. Rosen Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction Surg Innov 16 2009 324
29. A.G. Gristina Biomaterial-centered infection: microbial adhesion versus tissue integration Science 237 1987 1588
30. C. Kaito, and K. Sekimizu Colony spreading in Staphylococcus aureus J Bacteriol 189 2007 2553
31. M.W. Climo, R.L. Patron, and B.P. Goldstein Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis Antimicrob Agents Chemother 42 1998 1355
32. R.L. Patron, M.W. Climo, and B.P. Goldstein Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin Antimicrob Agents Chemother 43 1999 1754